Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stroke

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 96 articles:
HTML format
Text format



Single Articles


    August 2019
  1. MA H, Campbell BCV, Churilov L
    Thrombolysis up to 9 Hours after Onset of Stroke. Reply.
    N Engl J Med. 2019;381:488-489.
    PubMed     Text format    


  2. TAN B, Zaidat O
    Thrombolysis up to 9 Hours after Onset of Stroke.
    N Engl J Med. 2019;381:488.
    PubMed     Text format    


    July 2019
  3. FREEMAN MW, Singh AK, Guidon AC, Arvikar SL, et al
    Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.
    N Engl J Med. 2019;381:275-283.
    PubMed     Text format    


  4. FLINT AC, Conell C, Ren X, Banki NM, et al
    Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
    N Engl J Med. 2019;381:243-251.
    PubMed     Text format     Abstract available


    May 2019
  5. DIENER HC, Sacco RL, Easton JD, Granger CB, et al
    Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2019;380:1906-1917.
    PubMed     Text format     Abstract available


  6. MARSHALL RS
    Image-Guided Intravenous Alteplase for Stroke - Shattering a Time Window.
    N Engl J Med. 2019;380:1865-1866.
    PubMed     Text format    


  7. MA H, Campbell BCV, Parsons MW, Churilov L, et al
    Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
    N Engl J Med. 2019;380:1795-1803.
    PubMed     Text format     Abstract available


    April 2019
  8. MEHRA MR, Uriel N, Naka Y, Cleveland JC Jr, et al
    A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
    N Engl J Med. 2019;380:1618-1627.
    PubMed     Text format     Abstract available


  9. OMBRELLO AK, Qin J, Hoffmann PM, Kumar P, et al
    Treatment Strategies for Deficiency of Adenosine Deaminase 2.
    N Engl J Med. 2019;380:1582-1584.
    PubMed     Text format    


  10. NGUYEN G, Feigin V, Roth G
    Lifetime Risk of Stroke in the Global Burden of Disease Study. Reply.
    N Engl J Med. 2019;380:1378.
    PubMed     Text format    


  11. ZHAO HL, Huang Y
    Lifetime Risk of Stroke in the Global Burden of Disease Study.
    N Engl J Med. 2019;380:1377-1378.
    PubMed     Text format    


  12. LIU F, Huang K, Lu X
    Lifetime Risk of Stroke in the Global Burden of Disease Study.
    N Engl J Med. 2019;380:1377.
    PubMed     Text format    


    March 2019
  13. MACK MJ, Leon MB, Thourani VH, Makkar R, et al
    Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1814052.
    PubMed     Text format     Abstract available


  14. POPMA JJ, Deeb GM, Yakubov SJ, Mumtaz M, et al
    Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1816885.
    PubMed     Text format     Abstract available


    February 2019
  15. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Text format     Abstract available


    January 2019
  16. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    PubMed     Text format     Abstract available


    December 2018
  17. FEIGIN VL, Nguyen G, Cercy K, Johnson CO, et al
    Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.
    N Engl J Med. 2018;379:2429-2437.
    PubMed     Text format     Abstract available


    November 2018
  18. PROVENZANO AM
    Becoming a Caregiver - Lessons from My Dad.
    N Engl J Med. 2018;379:1696-1697.
    PubMed     Text format    


    October 2018
  19. YIN X, Wang D
    Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    


  20. JIA L, Ji H, Li R
    Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    



  21. Antiplatelet Agents in Acute Stroke and TIA.
    N Engl J Med. 2018;379:e29.
    PubMed     Text format    


  22. WUSSLER D, du Fay de Lavallaz J, Mueller C
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1580.
    PubMed     Text format    


  23. YIN X, Wang D
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1579-1580.
    PubMed     Text format    



  24. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018;379:1579-1581.
    PubMed     Text format    


    September 2018
  25. HARLOFF A, Schlachetzki F
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986-7.
    PubMed     Text format    


  26. SU Q, Li Q
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986.
    PubMed     Text format    


  27. GIRGIS M, Jelaidan I
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986.
    PubMed     Text format    



  28. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018;379:986-987.
    PubMed     Text format    


    August 2018
  29. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available


  30. SPYROPOULOS AC, Ageno W, Albers GW, Elliott CG, et al
    Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1805090.
    PubMed     Text format     Abstract available


  31. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Text format     Abstract available


  32. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Text format     Abstract available


    July 2018
  33. TAYLOR JB, Prager LM, Quijije NV, Schaefer PW, et al
    Case 21-2018: A 61-Year-Old Man with Grandiosity, Impulsivity, and Decreased Sleep.
    N Engl J Med. 2018;379:182-189.
    PubMed     Text format    


    May 2018
  34. HART RG, Sharma M, Mundl H, Kasner SE, et al
    Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802686.
    PubMed     Text format     Abstract available


  35. AMARENCO P, Lavallee PC, Monteiro Tavares L, Labreuche J, et al
    Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1802712.
    PubMed     Text format     Abstract available


  36. THOMALLA G, Simonsen CZ, Boutitie F, Andersen G, et al
    MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1804355.
    PubMed     Text format     Abstract available


  37. GROTTA JC
    Antiplatelet Therapy after Ischemic Stroke or TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMe1806043.
    PubMed     Text format    


  38. JOVIN TG
    MRI-Guided Intravenous Alteplase for Stroke - Still Stuck in Time.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMe1805796.
    PubMed     Text format    


  39. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Text format     Abstract available


  40. VINNY PW, Vishnu VY, Srivastava MVP
    Thrombectomy for Stroke with Selection by Perfusion Imaging.
    N Engl J Med. 2018;378:1849.
    PubMed     Text format    



  41. Thrombectomy for Stroke with Selection by Perfusion Imaging.
    N Engl J Med. 2018;378:1849-1850.
    PubMed     Text format    


    April 2018
  42. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed     Text format    


  43. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Text format     Abstract available


  44. MI MY, Block PC, Broderick JP
    PFO Closure for Cryptogenic Stroke.
    N Engl J Med. 2018;378:1639-1642.
    PubMed     Text format    


  45. ANDERSON CS, Woodward M, Chalmers J
    More on Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    N Engl J Med. 2018;378:1465-1466.
    PubMed     Text format    


    March 2018
  46. VINNY PW, Vishnu VY, Padma Srivastava MV
    Thrombectomy 6 to 24 Hours after Stroke.
    N Engl J Med. 2018;378:1161.
    PubMed     Text format    


  47. JOVIN TG, Nogueira RG
    Thrombectomy 6 to 24 Hours after Stroke.
    N Engl J Med. 2018;378:1161-1162.
    PubMed     Text format    


  48. MEHRA MR, Goldstein DJ, Uriel N, Cleveland JC Jr., et al
    Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
    N Engl J Med. 2018 Mar 11. doi: 10.1056/NEJMoa1800866.
    PubMed     Text format     Abstract available


    February 2018
  49. BAUASHVILI A, Evans AT
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:485.
    PubMed     Text format    


  50. DEKKERS T, Lafeber M, Kramers C
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484-5.
    PubMed     Text format    


  51. WANG X, Karnieg T
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484.
    PubMed     Text format    



  52. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:484-486.
    PubMed     Text format    


  53. PICCINI JP, Jones WS
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med. 2018;378:486.
    PubMed     Text format    


    January 2018
  54. ALBERS GW, Marks MP, Kemp S, Christensen S, et al
    Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
    N Engl J Med. 2018 Jan 24. doi: 10.1056/NEJMoa1713973.
    PubMed     Text format     Abstract available


  55. ZHENG MX, Hua XY, Feng JT, Li T, et al
    Trial of Contralateral Seventh Cervical Nerve Transfer for Spastic Arm Paralysis.
    N Engl J Med. 2018;378:22-34.
    PubMed     Text format     Abstract available


    December 2017
  56. BRAEMSWIG TB, Scheitz JF, Nolte CH
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2599.
    PubMed     Text format    


  57. COSMI D, Mariottoni B, Cosmi F
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2598-2599.
    PubMed     Text format    


  58. MAS JL, Derumeaux G, Chatellier G
    Trials of Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:2599-2600.
    PubMed     Text format    


  59. CUCULICH PS, Schill MR, Kashani R, Mutic S, et al
    Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia.
    N Engl J Med. 2017;377:2325-2336.
    PubMed     Text format     Abstract available


  60. VEDANTHAM S, Goldhaber SZ, Julian JA, Kahn SR, et al
    Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
    N Engl J Med. 2017;377:2240-2252.
    PubMed     Text format     Abstract available


    November 2017
  61. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Text format     Abstract available


  62. NOGUEIRA RG, Jadhav AP, Haussen DC, Bonafe A, et al
    Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.
    N Engl J Med. 2017 Nov 11. doi: 10.1056/NEJMoa1706442.
    PubMed     Text format     Abstract available


  63. HACKE W
    A New DAWN for Imaging-Based Selection in the Treatment of Acute Stroke.
    N Engl J Med. 2017 Nov 11. doi: 10.1056/NEJMe1713367.
    PubMed     Text format    


  64. GOLDSTONE AB, Chiu P, Baiocchi M, Lingala B, et al
    Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.
    N Engl J Med. 2017;377:1847-1857.
    PubMed     Text format     Abstract available


    September 2017
  65. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Text format     Abstract available


  66. SIBON I, Gerardin P, Gauthier A
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1101.
    PubMed     Text format    


  67. FELDMAN WB, Chiong W, Kim SYH
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1101-2.
    PubMed     Text format    


  68. MAS JL, Derumeaux G, Guillon B, Massardier E, et al
    Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    N Engl J Med. 2017;377:1011-1021.
    PubMed     Text format     Abstract available


  69. TAITO S, Yamauchi K
    Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1102.
    PubMed     Text format    



  70. Head Positioning in Acute Stroke.
    N Engl J Med. 2017;377:1102-3.
    PubMed     Text format    


  71. FARB A, Ibrahim NG, Zuckerman BD
    Patent Foramen Ovale after Cryptogenic Stroke - Assessing the Evidence for Closure.
    N Engl J Med. 2017;377:1006-1009.
    PubMed     Text format    


  72. SAVER JL, Carroll JD, Thaler DE, Smalling RW, et al
    Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
    N Engl J Med. 2017;377:1022-1032.
    PubMed     Text format     Abstract available


  73. SONDERGAARD L, Kasner SE, Rhodes JF, Andersen G, et al
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    N Engl J Med. 2017;377:1033-1042.
    PubMed     Text format     Abstract available


  74. ROPPER AH
    Tipping Point for Patent Foramen Ovale Closure.
    N Engl J Med. 2017;377:1093-1095.
    PubMed     Text format    


    June 2017
  75. ZHANG Y, Chen S, Tang W
    Two-Year Outcome after Endovascular Treatment for Stroke.
    N Engl J Med. 2017;376:2597.
    PubMed     Text format    



  76. Two-Year Outcome after Endovascular Treatment for Stroke.
    N Engl J Med. 2017;376:2597.
    PubMed     Text format    


  77. ANDERSON CS, Arima H, Lavados P, Billot L, et al
    Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.
    N Engl J Med. 2017;376:2437-2447.
    PubMed     Text format     Abstract available


    May 2017
  78. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Racial Disparities in Risks of Stroke.
    N Engl J Med. 2017;376:2089-2090.
    PubMed     Text format    


  79. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    PubMed     Text format     Abstract available


    April 2017
  80. REDA HM, Copen WA, Karaa A, Oakley DH, et al
    Case 13-2017. A 41-Year-Old Man with Hearing Loss, Seizures, Weakness, and Cognitive Decline.
    N Engl J Med. 2017;376:1668-1678.
    PubMed     Text format    


  81. VAN DEN BERG LA, Dijkgraaf MG, Berkhemer OA, Fransen PS, et al
    Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke.
    N Engl J Med. 2017;376:1341-1349.
    PubMed     Text format     Abstract available


    March 2017
  82. CALKINS H, Willems S, Gerstenfeld EP, Verma A, et al
    Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    N Engl J Med. 2017 Mar 19. doi: 10.1056/NEJMoa1701005.
    PubMed     Text format     Abstract available


  83. REARDON MJ, Van Mieghem NM, Popma JJ, Kleiman NS, et al
    Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1700456.
    PubMed     Text format     Abstract available


  84. SHARMA SHP
    Prevention of Bleeding in Atrial Fibrillation.
    N Engl J Med. 2017;376:993-4.
    PubMed     Text format    


  85. UREYEN CM, Vatan MB, Gunduz H
    Prevention of Bleeding in Atrial Fibrillation.
    N Engl J Med. 2017;376:993.
    PubMed     Text format    



  86. Prevention of Bleeding in Atrial Fibrillation.
    N Engl J Med. 2017;376:994.
    PubMed     Text format    


    February 2017
  87. ROGERS JG, Pagani FD, Tatooles AJ, Bhat G, et al
    Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.
    N Engl J Med. 2017;376:451-460.
    PubMed     Text format     Abstract available


    December 2016
  88. TAGGART DP, Altman DG, Gray AM, Lees B, et al
    Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
    N Engl J Med. 2016;375:2540-9.
    PubMed     Text format     Abstract available


    November 2016
  89. MEHRA MR, Naka Y, Uriel N, Goldstein DJ, et al
    A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    October 2016
  90. LAMY A, Devereaux PJ, Prabhakaran D, Taggart DP, et al
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  91. CULIC V
    Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:1394-1395.
    PubMed     Text format    


  92. LANDMAN GW, Kleefstra N
    Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:1394-1395.
    PubMed     Text format    



  93. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:1394-1395.
    PubMed     Text format    


    September 2016
  94. DHAKAL P, Verma V, Bhatt VR
    Cryptogenic Stroke.
    N Engl J Med. 2016;375:e26.
    PubMed     Text format    


  95. SPENCE JD
    Cryptogenic Stroke.
    N Engl J Med. 2016;375:e26.
    PubMed     Text format    


  96. SAVER JL
    Cryptogenic Stroke.
    N Engl J Med. 2016;375:e26.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: